On January 17, 2025, a class action lawsuit was filed against Innovative Industrial Properties, Inc. (“IIPR” or the “Company”) (NYSE: IIPR) on behalf of investors who acquired IIPR securities between February 27, 2024, and December 19, 2024 (the “Class Period”).

If you purchased or otherwise acquired IIPR shares during the Class Period, click here to send us a message for more information about the IIPR class action lawsuit.

How to Provide Information

To share details about your financial losses or to be contacted by a member of our team, please complete our brief securities questionnaire. Alternatively, you can reach out to Michael Yarnoff, Esq., for a no-obligation evaluation of potential legal claims:

• Email: myarnoff@kehoelawfirm.com or info@kehoelawfirm.com
• Phone: (215) 792-6676, Ext. 804

Class Action Lawsuit Allegations

According to the complaint, the defendants allegedly made materially false and misleading statements about the Company’s business, operations, and financial prospects during the Class Period. Specifically, the complaint alleges the following:

1. IIPR was experiencing significant declines in rent and property-management fees associated with certain customer leases.
2. These declines would likely impair the Company’s ability to maintain funds from operations (FFO) and revenue growth.
3. Consequently, IIPR’s leasing operations were less profitable than the Company had represented to investors.
4. As a result, IIPR’s public statements were materially false and misleading throughout the Class Period.

To review the complaint, click IIPR class action complaint.

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C., is a multidisciplinary, plaintiff-side class action law firm committed to protecting investors from securities fraud, breaches of fiduciary duties, and corporate misconduct. Collectively, the firm’s partners have served as Lead or Co-Lead Counsel in cases recovering over $10 billion on behalf of institutional and individual investors.

By clicking and submitting this form, you acknowledge that this does not establish an attorney-client relationship between you and Kehoe Law Firm, P.C. (“KLF” or “Firm”), and that the submission or receipt of information to the Firm or one of its attorneys via this form, website, email or telephone does not create an attorney-client relationship.  All submissions are confidential, and there is no cost or obligation incurred by providing your information to Kehoe Law Firm, P.C. By submitting this form, you authorize KLF to contact you regarding this or future cases. 

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Kehoe Law Firm, P.C. is investigating securities class action claims on behalf of shareholders of Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (NASDAQ: WBA).

WALGREENS INVESTORS WITH FINANCIAL LOSSES ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C. FOR A FREE, NO OBLIGATION EVALUATION OF POTENTIAL LEGAL CLAIMS.

Investors of Walgreens should be aware that the U.S. Department of Justice (“DOJ”) has filed a civil complaint in federal court alleging that Walgreens Boots Alliance, Walgreen Co. and various subsidiaries dispensed millions of unlawful prescriptions in violation of the Controlled Substances Act (“CSA”) and then sought reimbursement for many of these prescriptions from various federal health care programs in violation the False Claims Act (“FCA”).

According to the complaint, “. . . from approximately August 2012 through the present, Walgreens knowingly filled millions of prescriptions for controlled substances that lacked a legitimate medical purpose, were not valid, and/or were not issued in the usual course of professional practice. Among the millions of unlawful prescriptions that Walgreens allegedly filled were prescriptions for dangerous and excessive quantities of opioids, prescriptions for early refills of opioids and prescriptions for the especially dangerous and abused combination of drugs known as the ‘trinity,’ which is made up of an opioid, a benzodiazepine and a muscle relaxant.”

On this news, the stock price of Walgreens dropped more than 5% after the stock market closed on January 17, 2025.

WALGREENS SHAREHOLDERS INTERESTED IN LEARNING MORE ABOUT THE SECURITIES CLASS ACTION INVESTIGATION CAN ALSO EMAIL [email protected] OR CONTACT EITHER JOHN KEHOE, ESQ., (215) 792-6676, EXT. 801, [email protected], OR MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected].

PHONE

Tel: 215-792-6676

EMAIL

[email protected]